CN Bio Innovations Ltd

CN Bio Innovations Ltd

Address
332 Cambridge Science Park, Milton Road
Milton, Cambridge
Cambridgeshire, CB4 0WN
United Kingdom
Phone: +44 1223 737941
Visit Website Request Information/Quote Download PDF Copy

CN Bio is a leading organ-on-a-chip (OOC) company that offers a portfolio of products and contract research services to optimise the accuracy and efficiency of bringing new medicines to market. With more than a decade of research and development experience, we aim to transform the way human-relevant pre-clinical data is generated through the development of advanced in vitro human organ models.

CN-Bio's PhysioMimix® OOC range of microphysiological systems (MPS) enable researchers to recreate human biology in the lab. The technology bridges the gap between traditional cell culture and human studies, to support the development of safer and more efficacious therapeutics, whilst reducing the dependence on animal model usage.

CN Bio’s portfolio of products (MPS, 3D validated cells, consumable plates) and services support researchers that require reliable, data-rich, in vitro studies, to uncover novel mechanistic insights into drug or disease mechanism of action.

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies
CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing
CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA
CN Bio appoints Neil Rumbelow as Director of Product Development

CN Bio appoints Neil Rumbelow as Director of Product Development
CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems

CN Bio and LifeNet Health LifeSciences partner to supply validated primary human cells for microphysiological systems
CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer

CN Bio appoints Dr. Tomasz Kostrzewski as Chief Scientific Officer
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer

CN Bio appoints Dr. Samantha Macro as Chief Financial Officer

More News

Archived CN Bio Innovations Ltd News

Microphysiological systems in drug discovery

Microphysiological systems in drug discovery
Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery

Turning to Organ-on-a-Chip Studies for the Future of Drug Discovery
DILI assay kit: Human 24

DILI assay kit: Human 24
PhysioMimix® OOC Microphysiological Systems for microtissue culturing

PhysioMimix® OOC Microphysiological Systems for microtissue culturing
PhysioMimix® Compatible NASH-in-a-box

PhysioMimix® Compatible NASH-in-a-box
Physiomimix® Compatible 3D validated cells for the expedited delivery of human translatable data

Physiomimix® Compatible 3D validated cells for the expedited delivery of human translatable data
PhysioMimix® Barrier Plate for physiologically relevant barrier models

PhysioMimix® Barrier Plate for physiologically relevant barrier models
PhysioMimix® Dual-Organ Plate for organ-to-organ crosstalk investigation

PhysioMimix® Dual-Organ Plate for organ-to-organ crosstalk investigation
PhysioMimix® Liver-12 and -48 plates for in vitro 3D human liver tissue recreation

PhysioMimix® Liver-12 and -48 plates for in vitro 3D human liver tissue recreation
In vitro contract research services for rapid access to OOC technology

In vitro contract research services for rapid access to OOC technology
In vitro ADME services for measuring drug ADME without animal use

In vitro ADME services for measuring drug ADME without animal use
NASH in vitro services for fast-tracked OOC studies

NASH in vitro services for fast-tracked OOC studies
Drug-induced liver injury (DILI) in vitro services to predict human hepatotoxicity

Drug-induced liver injury (DILI) in vitro services to predict human hepatotoxicity
Advancing drug safety: Using human liver microphysiological systems to understand liver toxicity

Advancing drug safety: Using human liver microphysiological systems to understand liver toxicity
Could OOC technology replace the use of animals in research?

Could OOC technology replace the use of animals in research?
Decoding Organ-on-a-chip (OOC) success: Navigating the critical cell selection phase

Decoding Organ-on-a-chip (OOC) success: Navigating the critical cell selection phase
De-risking drug development: Using the power of Organ-on-a-Chip (OOC) to reduce liver injury

De-risking drug development: Using the power of Organ-on-a-Chip (OOC) to reduce liver injury
Exploring a human multi-organ microphysiological system for preclinical oral bioavailability profiling

Exploring a human multi-organ microphysiological system for preclinical oral bioavailability profiling
Harnessing alveolar and bronchial microphysiological systems for respiratory disease research and therapeutic testing

Harnessing alveolar and bronchial microphysiological systems for respiratory disease research and therapeutic testing
How a liver-on-a-chip model of fatty liver disease could assist in preventing a global healthcare crisis

How a liver-on-a-chip model of fatty liver disease could assist in preventing a global healthcare crisis
How are in vitro lung models propelling drug discovery?

How are in vitro lung models propelling drug discovery?
How does blood flow mimicking enhance Organ-on-a-Chip technology?

How does blood flow mimicking enhance Organ-on-a-Chip technology?
Making drug discovery more efficient by using human organ models

Making drug discovery more efficient by using human organ models
Modeling the interaction between the intestine and liver in a multi-organ microphysiological system for studying metabolic-dysfunction associated steatotic liver disease

Modeling the interaction between the intestine and liver in a multi-organ microphysiological system for studying metabolic-dysfunction associated steatotic liver disease
Using microphysiological systems to investigate fatty liver disease and drug-induced liver injury (DILI)

Using microphysiological systems to investigate fatty liver disease and drug-induced liver injury (DILI)
What are the current misconceptions surrounding organ-on-a-chip technology?

What are the current misconceptions surrounding organ-on-a-chip technology?
What are the sub-types of drug-induced liver injury (DILI)?

What are the sub-types of drug-induced liver injury (DILI)?
A breath of fresh air

A breath of fresh air
Beyond hepatotoxicity red flags

Beyond hepatotoxicity red flags
From dose to circulation: Determination of drug oral bioavailability using a gut-liver microphysiological system

From dose to circulation: Determination of drug oral bioavailability using a gut-liver microphysiological system
Improving drug development translation

Improving drug development translation
Liver-on-chip and in silico modeling for quantitative drug metabolism studies

Liver-on-chip and in silico modeling for quantitative drug metabolism studies
Mechanistic insights of toxicity

Mechanistic insights of toxicity
Set yourself up for success with organ-on-a-chip

Set yourself up for success with organ-on-a-chip
The Dash for NASH

The Dash for NASH
The human touch

The human touch
The rhythm of life

The rhythm of life
Validation criteria for a jejunum-hepatocyte dual-organ MPS for drug ADME studies

Validation criteria for a jejunum-hepatocyte dual-organ MPS for drug ADME studies

Trending Stories

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback